Result of AGM

Life Science REIT PLC

25 May 2023

 

Life Science REIT plc

(the "Company")

LEI: 213800RG7JNX7K8F7525

25 May 2023

Annual General Meeting ("AGM") Results

The Company announces that at its Annual General Meeting held earlier today all the resolutions set out in the Notice of Annual General Meeting were passed. All resolutions were voted on by way of a poll.  The results of the poll for each resolution were as follows:

Resolution	For		Against		Votes Withheld (No. of shares)
	No. of shares	%	No. of shares	%
1.   To receive and approve the annual report and financial statements	237,307,165	100.00%	10,345	0.00%	19,548
2.   To receive and approve the Directors' remuneration report	236,497,636	99.68%	761,688	0.32%	77,734
3.   To re-elect Claire Boyle as a Director of the Company	227,063,288	95.69%	10,227,912	4.31%	45,858
4.   To re-elect Sally Ann Forsyth as a Director of the Company	197,662,892	90.55%	20,630,888	9.45%	19,043,278
5.   To re-elect Michael Taylor as a Director of the Company	236,321,834	99.59%	969,366	0.41%	45,858
6.   To re-elect Richard Howell as a Director of the Company	236,350,144	99.59%	969,366	0.41%	17,548
7.   To appoint Deloitte LLP as Auditor to the Company	237,257,249	99.97%	63,261	0.03%	16,548
8.   To authorise the Audit and Risk Committee to determine the remuneration of the Auditor to the Company	237,267,855	99.99%	24,345	0.01%	44,858
9.   To approve the Company's dividend payment policy	237,287,855	100.00%	10,345	0.00%	38,858
10.  To authorise the Directors to allot equity securities	228,003,637	96.08%	9,294,563	3.92%	38,858
11.  To authorise the Directors to disapply pre-emption rights*	226,872,038	95.61%	10,420,162	4.39%	44,858
12.  To authorise the Directors to disapply pre-emption rights for the purposes of financing an acquisition or other capital investment*	225,728,875	95.13%	11,563,325	4.87%	44,858
13.  To approve the purchase of the Company's own shares*	227,477,570	95.87%	9,800,639	4.13%	58,849
14.  That a general meeting, other than an AGM, may be called on not less than 14 clear days' notice*	236,894,091	99.83%	404,109	0.17%	38,858

*special resolution

NOTES:
1.	All resolutions were passed.
2.	Percentages have been rounded to two decimal places.
3.	Proxy appointments which gave discretion to the Chair of the AGM have been included in the "For" total for the appropriate resolution.
4.	Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution.
5.	A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" any resolution.
6.	The number of shares in issue at 6:00 pm. on 23 May 2023 was 350,000,000 ordinary shares, carrying one vote each, and at that time, the Company did not hold any shares in treasury.
7.	The full text of the resolutions passed at the AGM can be found in the Notice of Annual General Meeting which is available on the Company's website at https://lifesciencereit.co.uk/investors/shareholder-information/

 

END